Hillcrest Hospital is a comprehensive-care hospital on Mayfield Road in Mayfield Heights, Ohio, United States. It is part of the Cleveland Clinic Health System. The hospital currently has 500 registered beds, and serves as a level II trauma center for eastern Cuyahoga, Geauga, Lake, and Portage counties.

There are 500 beds in Cleveland Clinic Hillcrest Hospital.

During the past decade, Cleveland Clinic Hillcrest Hospital conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 6 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 2 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cleveland Clinic Hillcrest Hospital" #1 sponsor was "The Cleveland Clinic" with 8 trials, followed by "Pfizer" with 3 trials sponsored, "Seagen Inc." with 2 trials sponsored, "CanariaBio Inc." with 1 trials sponsored and "Daiichi Sankyo, Inc." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cleveland Clinic Hillcrest Hospital" #1 collaborator was "Genmab" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Amarex Clinical Research" with 1 trials as a collaborator, "American Greetings" with 1 trials as a collaborator and "Arrowhead Regional Medical Center" with 1 trials as a collaborator. Other collaborators include 75 different institutions and companies that were collaborators in the rest 85 trials.

According to Clinical.Site data, the most researched conditions in "Cleveland Clinic Hillcrest Hospital" are "Ovarian Cancer" (4 trials), "Fallopian Tube Cancer" (2 trials), "Ovarian Neoplasms" (2 trials), "Pain" (2 trials) and "Peritoneal Cancer" (2 trials). Many other conditions were trialed in "Cleveland Clinic Hillcrest Hospital" in a lesser frequency.

Most popular intervention types in "Cleveland Clinic Hillcrest Hospital" are "Drug" (16 trials), "Other" (7 trials), "Biological" (3 trials), "Behavioral" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "tisotumab vedotin" (2 trials), "Anti-hypertensive therapy" (1 trials), "Artesunate vaginal insert" (1 trials) and "Biorepository" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cleveland Clinic Hillcrest Hospital" are 11 trials for "Female" genders, 10 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Cleveland Clinic Hillcrest Hospital". undefined are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Cleveland Clinic Hillcrest Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Cleveland Clinic Hillcrest Hospital, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".